AFP reports that 2,250 people from different countries – from Great Britain, South Africa, Brazil and Poland – will be recruited for the second and third phases of the tests. at Serum A “vector” (adenovirus) technology is used, which is used in Vaccines Against Covid-19 around the world.
“Testing doses that enhance existing vaccines and those of new variants is important to ensure we are well prepared to handle pandemi ± coronavirus, said Oxford University Vaccine Group Director Andrew Pollard.
Data from clinical trials will be submitted to vaccine availability regulators for evaluation in an accelerated process. If the vaccine is approved, it will be the first vaccine to be used against a specific type of coronavirus.
in May rz ± d The British announced that clinical trials have begun to investigate the body’s immune response to the third dose of the Covid-19 vaccine due to the increase in infections with the Delta type of Corona virus.
“Internet Geek. Food Enthusiast. Thinker. Beer Practitioner. Bacon Specialist. Music Addict. Traveler.”